RUA Life Sciences plc
RUA.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £3,567 | £3,931 | £1,484 | £2,963 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £1,092 | £532 | £588 | £1,120 |
| Inventory | £754 | £112 | £81 | £124 |
| Other Curr. Assets | £0 | £189 | -£166 | -£342 |
| Total Curr. Assets | £5,413 | £4,993 | £2,153 | £4,207 |
| Property Plant & Equip (Net) | £3,166 | £2,456 | £2,739 | £2,597 |
| Goodwill | £301 | £301 | £301 | £301 |
| Intangibles | £375 | £419 | £771 | £822 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | -£301 | -£301 |
| Total NC Assets | £3,842 | £3,176 | £3,510 | £3,419 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £9,255 | £8,169 | £5,663 | £7,626 |
| Liabilities | – | – | – | – |
| Payables | £683 | £140 | £43 | £185 |
| Short-Term Debt | £234 | £31 | £29 | £23 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £29 | £75 | £57 | £113 |
| Total Curr. Liab. | £1,102 | £554 | £414 | £511 |
| LT Debt | £19 | £132 | £165 | £199 |
| Deferred Rev, NC | £0 | £0 | £116 | £174 |
| Deferred Tax Liab, NC | £0 | £74 | £85 | £75 |
| Other NC Liab. | £122 | £87 | £0 | £0 |
| Total NC Liab. | £761 | £433 | £566 | £531 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £776 | £226 | £200 | £83 |
| Total Liabilities | £1,863 | £987 | £980 | £1,042 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £3,103 | £3,103 | £1,109 | £1,109 |
| Retained Earnings | -£19,979 | -£19,985 | -£18,545 | -£16,542 |
| AOCI | £10,465 | £10,355 | £10,390 | £10,288 |
| Other Equity | £0 | £0 | £0 | £0 |
| Total Equity | £7,298 | £7,182 | £4,683 | £6,584 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £94 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £9,255 | £8,169 | £5,663 | £7,626 |
| Net Debt | -£3,314 | -£3,768 | -£1,290 | -£2,741 |